Oral Candidiasis in Newborns
Introduction
- Newborns commonly develop thrush (oral candidiasis), especially in the first few weeks of life due to their immature immune systems and exposure to Candida species during birth or through breastfeeding, according to the Clinical Infectious Diseases and Clinical Microbiology and Infection guidelines 1, 2
Etiology and Risk Factors
- Oral thrush in newborns is primarily caused by Candida albicans, which accounts for the majority of neonatal candidal infections, as stated by the Clinical Microbiology and Infection guideline 2
- Key risk factors for oral thrush in newborns include prematurity, exposure during vaginal delivery if the mother has vaginal candidiasis, breastfeeding from a mother with Candida infection of the breasts, use of broad-spectrum antibiotics, compromised immune system, and use of pacifiers or bottles that may harbor the fungus 2
Clinical Presentation
- Thrush in newborns typically presents as white, curd-like patches on the tongue, gums, inside of cheeks, or roof of the mouth, which do not wipe away easily, and may be accompanied by discomfort during feeding, as described by the Clinical Infectious Diseases guideline 1
Diagnosis
- Diagnosis of oral thrush in newborns is usually clinical, based on the characteristic appearance of white patches on oral mucosal surfaces, according to the Clinical Microbiology and Infection guideline 2
Treatment
- The American Academy of Pediatrics recommends first-line treatment with Nystatin oral suspension, with a dosage of 1 mL (100,000 units) four times daily, and continuation for at least 48 hours after symptoms resolve, as stated by the Clinical Infectious Diseases guideline 1
- If Nystatin fails or in severe cases, Fluconazole may be used, with a dosage of 3 mg/kg once daily for 7 days, and use with caution due to concerns about developing triazole resistance, as recommended by the Clinical Infectious Diseases guideline 3
- For concurrent maternal breast infection, treatment of both mother and infant is necessary to prevent reinfection, as stated by the Clinical Microbiology and Infection guideline 2
Prevention and Control
- Treatment of maternal vaginal candidiasis prior to delivery may prevent neonatal colonization, according to the Clinical Microbiology and Infection guideline 2
- Rigorous infection control measures in NICUs, rational use of broad-spectrum antibiotics, keeping the diaper area clean and dry, and addressing underlying causes of gastroesophageal reflux and vomiting are recommended to prevent horizontal transmission, as stated by the Clinical Microbiology and Infection guideline 2
Complications and Special Considerations
- Premature neonates are at higher risk for invasive candidiasis and require more vigilant monitoring, as stated by the Clinical Infectious Diseases guideline 1
- Cutaneous candidiasis can potentially become invasive and lead to disseminated disease in premature neonates, according to the Clinical Infectious Diseases guideline 1
- For extensive rash or signs of systemic involvement, consideration of systemic antifungal therapy is recommended, as stated by the Clinical Infectious Diseases guideline 1
- Amphotericin B deoxycholate at 1 mg/kg daily is recommended for neonates with disseminated candidiasis, according to the Clinical Infectious Diseases guideline 1, 4
- Lumbar puncture and dilated retinal examination are recommended if blood/urine cultures are positive for Candida species, as stated by the Clinical Infectious Diseases guideline 1, 4
- Central venous catheter removal is strongly recommended if present, according to the Clinical Infectious Diseases guideline 1, 4